Literature DB >> 17108674

Prevalence of two tumor necrosis factor gene polymorphisms in premature infants with early onset sepsis.

A C Schueller1, A Heep, E Kattner, M Kroll, M Wisbauer, J Sander, P Bartmann, F Stuber.   

Abstract

BACKGROUND: Tumor necrosis factor (TNF) is a central mediator of sepsis. The NcoI polymorphism within the TNF locus has been described as a prognostic marker for mortality in adult patients with sepsis.
OBJECTIVES: The aim of our study was to investigate the genotype and allele distribution of 2 TNF gene polymorphisms in preterm infants <32 weeks of gestational age, who developed early-onset sepsis.
METHODS: A double-blinded retrospective cohort study was carried out on stored Guthrie blood spot cards with group A including 67 premature infants <32 weeks of gestational age with proven early-onset sepsis and group B including 102 healthy newborn infants (>32 + 0 weeks of gestation). The genotype andallele distribution of the study population were also compared to reference groups of healthy adult volunteers (n = 252 for TNF-beta NcoI and n = 233 for -308 TNF-alpha promoter). Polymorphisms of the TNF-alpha promoter -308 region and the NcoI site of the TNF-beta gene were assessed using PCR followed by melting curve analysis or NcoI digestion. The groups were compared by estimation of Hardy-Weinberg equilibrium.
RESULTS: The overall allele frequency and genotype distribution of the -308 TNF-alpha and NcoI polymorphism of the TNF-beta gene were comparable to the values found in the controls.
CONCLUSION: The study results suggest that none of the analyzed TNF gene polymorphisms may serve as a prognostic marker for preterm infants at high risk of sepsis. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108674     DOI: 10.1159/000093605

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  10 in total

Review 1.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 2.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 3.  Association between innate immunity gene polymorphisms and neonatal sepsis development: a systematic review and meta-analysis.

Authors:  Tamara Sljivancanin Jakovljevic; Jelena Martic; Jelena Jacimovic; Nadja Nikolic; Jelena Milasin; Tanja Lazić Mitrović
Journal:  World J Pediatr       Date:  2022-06-06       Impact factor: 9.186

4.  Genetic polymorphisms and posttraumatic complications.

Authors:  Wei Gu; Jianxin Jiang
Journal:  Comp Funct Genomics       Date:  2011-01-11

5.  Laboratory aid to the diagnosis and therapy of infection in the neonate.

Authors:  Gaetano Chirico; Cristina Loda
Journal:  Pediatr Rep       Date:  2011-02-24

6.  Association between the Lymphotoxin-α A252g Gene Polymorphism and the Risk of Sepsis and Mortality: A Meta-Analysis.

Authors:  Shujin Guo; Qiunan Zuo; Xiaohui Li; Ye He; Yutian Zhou
Journal:  Biomed Res Int       Date:  2020-08-20       Impact factor: 3.411

7.  Neonatal infections in Saudi Arabia: Association with cytokine gene polymorphisms.

Authors:  Gamal Allam; Adnan A Alsulaimani; Ali K Alzaharani; Amre Nasr
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

8.  The effects of tumor necrosis factor-α (TNF-α) rs1800629 and rs361525 polymorphisms on sepsis risk.

Authors:  Yixin Zhang; Xiaoteng Cui; Li Ning; Dianjun Wei
Journal:  Oncotarget       Date:  2017-11-30

9.  Tumor necrosis factor-α -308 G/A polymorphism and risk of sepsis, septic shock, and mortality: an updated meta-analysis.

Authors:  Hao Wang; Shujin Guo; Chun Wan; Ting Yang; Ni Zeng; Yanqiu Wu; Lei Chen; Yongchun Shen; Fuqiang Wen
Journal:  Oncotarget       Date:  2017-09-13

10.  Evaluation of TNF-α genetic polymorphisms as predictors for sepsis susceptibility and progression.

Authors:  Anca Meda Georgescu; Claudia Banescu; Razvan Azamfirei; Adina Hutanu; Valeriu Moldovan; Iudita Badea; Septimiu Voidazan; Minodora Dobreanu; Ioana Raluca Chirtes; Leonard Azamfirei
Journal:  BMC Infect Dis       Date:  2020-03-14       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.